483
Spectrum Pharmaceuticals, Inc.Spectrum Pharmaceuticals, Inc. – FDA 483, May 27, 2016
Record Details
Spectrum Pharmaceuticals Inc. in Irvine, CA, was cited for significant deficiencies in its clinical trial monitoring processes. The inspection revealed failures to properly report protocol deviations in submitted NDA data listings and delays in drafting and submitting monitoring reports. Additionally, the firm did not promptly address and document non-compliance by investigators, lacking evidence of corrective actions or a developed plan.
View Company Profile
ID · f1b02020-a69a-4ae1-a502-d4bd9cca549b
Other documents for Spectrum Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.